Woodstock Corp’s Vertex Pharmaceuticals VRTX Stock Holding History

Woodstock Corp’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99M	Hold	4,005	–	–	0.17%	91
2026 Q1	$1.79M	Hold	4,005	–	–	0.16%	90
2025 Q4	$1.82M	Hold	4,005	–	–	0.16%	89
2025 Q3	$1.57M	Hold	4,005	–	–	0.14%	90
2025 Q2	$1.78M	Sell	4,005 -172	-4%	-$79.3K	0.16%	90
2025 Q1	$2.03M	Hold	4,177	–	–	0.2%	86
2024 Q4	$1.68M	Hold	4,177	–	–	0.16%	91
2024 Q3	$1.94M	Hold	4,177	–	–	0.19%	87
2024 Q2	$1.96M	Hold	4,177	–	–	0.2%	85
2024 Q1	$1.75M	Hold	4,177	–	–	0.18%	88
2023 Q4	$1.7M	Hold	4,177	–	–	0.2%	86
2023 Q3	$1.45M	Hold	4,177	–	–	0.18%	85
2023 Q2	$1.47M	Hold	4,177	–	–	0.17%	85
2023 Q1	$1.32M	Hold	4,177	–	–	0.17%	88
2022 Q4	$1.21M	Hold	4,177	–	–	0.16%	89
2022 Q3	$1.21M	Buy	4,177 +100	+2%	+$28.8K	0.18%	86
2022 Q2	$1.15M	Hold	4,077	–	–	0.16%	91
2022 Q1	$1.06M	Sell	4,077 -212	-5%	-$50.3K	0.12%	96
2021 Q4	$942K	Hold	4,289	–	–	0.1%	104
2021 Q3	$778K	Hold	4,289	–	–	0.09%	112
2021 Q2	$865K	Hold	4,289	–	–	0.1%	109
2021 Q1	$922K	Sell	4,289 -728	-15%	-$160K	0.12%	104
2020 Q4	$1.19M	Buy	5,017 +678	+16%	+$156K	0.16%	90
2020 Q3	$1.18M	Hold	4,339	–	–	0.19%	77
2020 Q2	$1.26M	Hold	4,339	–	–	0.21%	77
2020 Q1	$1.03M	Buy	4,339 +50	+1%	+$11.5K	0.21%	80
2019 Q4	$939K	Hold	4,289	–	–	0.15%	94
2019 Q3	$727K	Sell	4,289 -30	-0.7%	-$5.31K	0.13%	99
2019 Q2	$792K	Hold	4,319	–	–	0.14%	102
2019 Q1	$794K	Hold	4,319	–	–	0.14%	101
2018 Q4	$716K	Hold	4,319	–	–	0.14%	99
2018 Q3	$832K	Hold	4,319	–	–	0.14%	102
2018 Q2	$734K	Hold	4,319	–	–	0.14%	104
2018 Q1	$704K	Hold	4,319	–	–	0.13%	104
2017 Q4	$647K	Hold	4,319	–	–	0.12%	108
2017 Q3	$657K	Hold	4,319	–	–	0.13%	107
2017 Q2	$557K	Hold	4,319	–	–	0.11%	115
2017 Q1	$472K	Hold	4,319	–	–	0.1%	116
2016 Q4	$318K	Sell	4,319 -854	-17%	-$69.5K	0.06%	133
2016 Q3	$451K	Hold	5,173	–	–	0.09%	119
2016 Q2	$445K	Sell	5,173 -4	-0.1%	-$346	0.09%	117
2016 Q1	$412K	Hold	5,177	–	–	0.09%	119
2015 Q4	$651K	Hold	5,177	–	–	0.14%	101
2015 Q3	$539K	Hold	5,177	–	–	0.12%	108
2015 Q2	$639K	Sell	5,177 -3,965	-43%	-$500K	0.12%	107
2015 Q1	$1.08M	Sell	9,142 -2,861	-24%	-$343K	0.2%	95
2014 Q4	$1.43M	Hold	12,003	–	–	0.26%	89
2014 Q3	$1.35M	Hold	12,003	–	–	0.26%	88
2014 Q2	$1.14M	Hold	12,003	–	–	0.2%	92
2014 Q1	$849K	Hold	12,003	–	–	0.16%	101
2013 Q4	$892K	Hold	12,003	–	–	0.16%	101
2013 Q3	$910K	Hold	12,003	–	–	0.18%	95
2013 Q2	$961K	Buy	+12,003	New	+$884K	0.2%	93

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Woodstock Corp's VRTX Position: Q2 2026 in Review

Woodstock Corp held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 4,005 shares worth $1.99M. The position accounts for 0.17% of the portfolio, ranked #91.

Woodstock Corp first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.03M in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Woodstock Corp held 4,005 shares of Vertex Pharmaceuticals worth $1.99M as of Q2 2026.
Woodstock Corp left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.17% of Woodstock Corp's portfolio in Q2 2026, its #91 holding.
Woodstock Corp first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
Woodstock Corp's Vertex Pharmaceuticals position peaked at $2.03M in Q1 2025.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Woodstock Corp's 13F filing for Q2 2026, filed 13 Jul 2026.